针对受体结合域和肝素硫酸盐结合,用于针对SARS-CoV-2变种的抗病毒药物开发
Zi-Sin Yang1,2, Tzong-Shiun Li3,4, Yu-Sung Huang2
1Department of Medical Sciences Industry, College of Health Sciences, Chang Jung Christian University, Tainan, 711, Taiwan.
Scientific reports
|February 2, 2024
概括
新的计算方法通过准尖端蛋白质来确定天然化合物乙化物,超化物和异quercitrin 作为针对 SARS-CoV-2 变体的潜在药物.
科学领域:
- 计算病毒学和药物发现.
- 结构生物学和分子建模.
背景情况:
- 新出现的SARS-CoV-2变种降低了现有的抗病毒药物和疫苗的有效性.
- 尖端蛋白的受体结合域 (RBD) 对于病毒进入至关重要.
- 主体细胞上的肝硫酸盐 (HS) 在SARS-CoV-2感染中起着重要作用.
研究的目的:
- 在SARS-CoV-2尖端蛋白RBD中识别保存序列和可用药物的口袋,用于抗病毒药物开发.
- 为了研究肝素硫酸盐 (HS) 和SARS-CoV-2尖端蛋白的RBD之间的结合相互作用.
- 选天然化合物对抗SARS-CoV-2变种的潜在抗病毒活性.
主要方法:
- 利用计算方法,包括多重序列分析,研究HS-RBD结合.
- 使用对接模拟 (LibDock,Autodock vina) 和分子动力学 (MD) 模拟 (AMBER20) 来选天然产品.
- 在RBD中确定了针对药物设计的潜在热点 (R454,E471).
主要成果:
- 在HS-RBD结合区域中发现了强烈的相互作用,突出显示了R454和E471作为关键热点.
- 选了天然产品数据库,并确定了三种化合物 - - 乙酸 (ACE),超酸 (HYP) 和异基 (ISO) - - 对RBD有强烈的亲和力.
- 证明了这些化合物的潜力,作为针对SARS-CoV-2的抗病毒药物开发的候选者.
结论:
- 基于结构的计算方法是有效的识别潜在的抗病毒药物向病毒葡萄糖蛋白-宿主受体相互作用.
- 乙化物,超化物和异quercitrin 显示承诺作为新型抗病毒药物对抗SARS-CoV-2变种.
- 这一战略为开发新疗法以对抗不断变化的病毒威胁提供了一条可行的途径.
相关概念视频
Targets for Drug Action: Overview
9.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Inhibitors of Viral Protein Synthesis
58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58


